Century Therapeutics, Inc. (IPSC): Price and Financial Metrics

Century Therapeutics, Inc. (IPSC): $0.73

0.03 (-4.31%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add IPSC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#78 of 340

in industry

IPSC Price/Volume Stats

Current price $0.73 52-week high $5.51
Prev. close $0.76 52-week low $0.72
Day low $0.72 Volume 347,479
Day high $0.78 Avg. volume 518,972
50-day MA $1.09 Dividend yield N/A
200-day MA $1.89 Market Cap 62.07M

IPSC Stock Price Chart Interactive Chart >


Century Therapeutics, Inc. (IPSC) Company Bio


Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT or CAR-iNK candidate targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; and CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia. The company was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.


IPSC Latest News Stream


Event/Time News Detail
Loading, please wait...

IPSC Latest Social Stream


Loading social stream, please wait...

View Full IPSC Social Stream

IPSC Price Returns

1-mo -31.78%
3-mo -49.31%
6-mo -57.56%
1-year -83.60%
3-year -94.15%
5-year N/A
YTD -27.72%
2024 -69.58%
2023 -35.28%
2022 -67.65%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!